You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

CLINICAL TRIALS PROFILE FOR TRANXENE SD

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for TRANXENE SD

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00775996 ↗	Bioequivalence Study of Clorazepate Dipotassium 15mg Tablets Under Fasting Conditions	Completed	Ranbaxy Laboratories Limited	N/A	2003-08-01	The objective of this study was to compare the single-dose relative bioavailability of Ranbaxy and Abbott (TranxeneeT-Tab®) 15 mg clorazepate dipotassium tablets under fasting conditions.
NCT02323659 ↗	Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell Lymphomas	Unknown status	Polish Lymphoma Research Group	Phase 4	2014-06-01	Comparison of methotrexate versus interferon-alfa 2b on efficacy, safety and quality of life in patients with primary cutaneous T-cell lymphomas after failure of topical or phototherapy treatment.
NCT04726592 ↗	Efficacy of CLORazepate for the Treatment of MIGraine Attack in the Emergency Room	Recruiting	Assistance Publique - Hôpitaux de Paris	Phase 3	2021-07-08	The purpose of this study is to evaluate the efficacy of clorazepate in addition to the usual medication for treating migraine attack in the emergency room
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for TRANXENE SD

Condition Name

Chart
Table

Condition Name for TRANXENE SD
Intervention	Trials
Healthy	1
Lymphoma, T-Cell, Cutaneous	1
Migraine	1
Migraine With Aura	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for TRANXENE SD
Intervention	Trials
Migraine without Aura	1
Lymphoma, T-Cell, Cutaneous	1
Migraine with Aura	1
Lymphoma, T-Cell	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for TRANXENE SD

Trials by Country

Map
Table

Trials by Country for TRANXENE SD
Location	Trials
Poland	1
United States	1
France	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for TRANXENE SD
Location	Trials
Nebraska	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for TRANXENE SD

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for TRANXENE SD
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	1
N/A	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for TRANXENE SD
Clinical Trial Phase	Trials
Recruiting	1
Unknown status	1
Completed	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for TRANXENE SD

Sponsor Name

Chart
Table

Sponsor Name for TRANXENE SD
Sponsor	Trials
Ranbaxy Laboratories Limited	1
Polish Lymphoma Research Group	1
Assistance Publique - Hôpitaux de Paris	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for TRANXENE SD
Sponsor	Trials
Other	2
Industry	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.